Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
- PMID: 22171680
- DOI: 10.1111/j.1365-2133.2011.10630.x
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
Abstract
Androgenetic alopecia affects both men and women. In men it produces male pattern hair loss with bitemporal recession and vertex baldness. In women it produces female pattern hair loss (FPHL) with diffuse alopecia over the mid-frontal scalp. FPHL occurs as a result of nonuniform hair follicle miniaturization within follicular units. Diffuse alopecia is produced by a reduction in the number of terminal fibres per follicular unit. Baldness occurs only when all hairs within the follicular units are miniaturized and is a relatively late event in women. The concepts of follicular units and primary and secondary hair follicles within follicular units are well established in comparative mammalian studies, particularly in sheep. However, discovery of these structures in the human scalp hair and investigation of the changes in follicular unit anatomy during the development of androgenetic alopecia have provided a clearer understanding of the early stages of androgenetic alopecia and how the male and female patterns of hair loss are related. FPHL is the most common cause of alopecia in women and approximately one-third of adult caucasian women experience hair loss. The impact of FPHL is predominantly psychological. While men anticipate age-related hair loss, hair loss in women is usually unexpected and unwelcome at any age. Treatment options to arrest hair loss progression and stimulate partial hair regrowth for FPHL include the androgen receptor antagonists spironolactone and cyproterone acetate, the 5α-reductase inhibitor finasteride and the androgen-independent hair growth stimulator minoxidil. These treatments appear to work best when initiated early. Hair transplantation should be considered in advanced FPHL that is resistant to medical treatments. Hair transplantation requires well-preserved hair growth over the occipital donor area. The psychological impact of FPHL may also be reduced by cosmetic products that improve the appearance of the hair. These agents work to minimize hair fibre breakage, improve hair volume or conceal visible bald scalp.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.
Similar articles
-
Hair loss in women.Semin Cutan Med Surg. 2009 Mar;28(1):19-32. doi: 10.1016/j.sder.2009.01.001. Semin Cutan Med Surg. 2009. PMID: 19341939 Review.
-
Female pattern hair loss.Curr Probl Dermatol. 2015;47:45-54. doi: 10.1159/000369404. Epub 2015 Feb 20. Curr Probl Dermatol. 2015. PMID: 26370643 Review.
-
Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment.Dermatol Clin. 2013 Jan;31(1):119-27. doi: 10.1016/j.det.2012.08.005. Epub 2012 Oct 11. Dermatol Clin. 2013. PMID: 23159181 Review.
-
Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.Dermatol Clin. 2010 Jul;28(3):611-8. doi: 10.1016/j.det.2010.03.011. Dermatol Clin. 2010. PMID: 20510769
-
Female pattern hair loss.Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):626-40. doi: 10.4103/0378-6323.116732. Indian J Dermatol Venereol Leprol. 2013. PMID: 23974580 Review.
Cited by
-
A Case of Contact Allergic Dermatitis to Topical Minoxidil.Cureus. 2021 Jan 5;13(1):e12510. doi: 10.7759/cureus.12510. Cureus. 2021. PMID: 33564516 Free PMC article.
-
Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024.PLoS One. 2025 Mar 24;20(3):e0309849. doi: 10.1371/journal.pone.0309849. eCollection 2025. PLoS One. 2025. PMID: 40127098 Free PMC article.
-
Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center.Int J Trichology. 2016 Apr-Jun;8(2):57-61. doi: 10.4103/0974-7753.188033. Int J Trichology. 2016. PMID: 27601857 Free PMC article.
-
[Spironolactone in dermatological treatment. On and off label indications].Hautarzt. 2013 Oct;64(10):762-7. doi: 10.1007/s00105-013-2597-y. Hautarzt. 2013. PMID: 24150826 German.
-
Alopecia with endocrine therapies in patients with cancer.Oncologist. 2013;18(10):1126-34. doi: 10.1634/theoncologist.2013-0193. Epub 2013 Sep 13. Oncologist. 2013. PMID: 24037977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical